Fulcrum Therapeutics, Inc. (FULC) market cap

Market cap today
$286.43M

Fulcrum Therapeutics, Inc. (FULC) has a market cap of $286.43M. At the end of fiscal 2025 (December 31, 2025) its market cap was $716.55M. That is 146.0% higher than the $291.32M of fiscal 2024. Today's figure is 60.0% below the fiscal 2025 year-end. Figures as of 18 Nov 2026, 07:05 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Market cap today
$286.43M
Market cap, fiscal 2025
$716.55M
Change on fiscal 2024
+146.0%
Growth, 5 years
+19.2% a year
Highest on record
$716.55Mfiscal 2025
Lowest on record
$291.32Mfiscal 2024
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Fulcrum Therapeutics, Inc. market cap, in more detail

Over the five fiscal years to 2025 the market cap grew at a compound 19.2% a year. Across the 6 fiscal year-ends on record (2020–2025), the highest was $716.55M in fiscal 2025 and the lowest $291.32M in fiscal 2024.

History · 6 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Fulcrum Therapeutics, Inc. market cap, year by year

Fulcrum Therapeutics, Inc. (FULC) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$286.43M—$3.75—
2025$716.55M 146.0% up$11.3163.36M
2024$291.32M 29.6% down$4.7061.98M
2023$413.84M 26.4% up$6.7561.31M
2022$327.53M 47.6% down$7.2844.99M
2021$624.53M 110.1% up$17.6935.30M
2020$297.24M—$11.7125.38M
2019——$16.64—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

More on FULC

Fulcrum Therapeutics, Inc., figure by figure

Fulcrum Therapeutics, Inc. (FULC) overview: price, valuation and scorecard

Fulcrum Therapeutics, Inc. market cap: questions and answers

What is Fulcrum Therapeutics, Inc.'s market cap?

Fulcrum Therapeutics, Inc. (FULC) has a market cap of $286.43M. At the end of fiscal 2025 (December 31, 2025) its market cap was $716.55M. That is 146.0% higher than the $291.32M of fiscal 2024.

What is the growth rate of Fulcrum Therapeutics, Inc.'s market cap?

Over the five fiscal years to 2025 the market cap grew at a compound 19.2% a year.

What are the highest and lowest market cap figures on record for Fulcrum Therapeutics, Inc.?

Across the 6 fiscal year-ends on record (2020–2025), the highest was $716.55M in fiscal 2025 and the lowest $291.32M in fiscal 2024.

How is Fulcrum Therapeutics, Inc.'s market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Fulcrum Therapeutics, Inc. (FULC) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/FULC/market-cap

Underlying data: the company's filings with the SEC and Yahoo Finance.